Navigation

Home > Resources > Publications > The Importance of Gender in Emerging Infectious Diseases Data

The Importance of Gender in Emerging Infectious Diseases Data

Download Document:
PDF document icon

fs-17-205a-en.pdf — PDF document, 64 kB (66,239 bytes)

Author(s): MEASURE Evaluation

Year: 2017

The Importance of Gender in Emerging Infectious Diseases Data

Abstract:

Addressing gender when monitoring and evaluating emerging infectious disease (ID) interventions and programs helps to ensure equity in access and benefits for men and women. This brief explores the importance of gender in monitoring and evaluation (M&E) activities and suggests indicators to reveal and explain gender gaps in emerging ID outcomes.

Filed under: Gender , Infectious disease , Monitoring, Evaluation

TB DIAH will run until September 2023, PMI Measure Malaria until June 2024, and D4I until September 2023.

MEASURE Evaluation is funded by USAID to strengthen capacity in developing countries to gather, interpret, and use data to improve health. We create tools and approaches for rigorous evaluations, providing evidence to address health challenges. And we strengthen health information systems so countries can make better decisions and sustain good health outcomes over time.

MEASURE Evaluation
Carolina Population Center
University of North Carolina at Chapel Hill
123 W Franklin St
Chapel Hill, North Carolina 27516
Email: measure@unc.edu
www.measureevaluation.org

MEASURE Evaluation is funded by the United States Agency for International Development (USAID) and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). The information provided on this web site is not official U.S. government information and does not necessarily represent the views of USAID, PEPFAR or the U.S. government.

The Importance of Gender in Emerging Infectious Diseases Data

Personal tools